Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 5.0 | 2.1 | 1.0 | 0.9 |
| Revenue growth | 141.3% | 110.1% | 10.6% | |
| Cost of goods sold | 1.7 | 1.1 | 0.5 | 0.5 |
| Gross profit | 3.3 | 1.0 | 0.5 | 0.4 |
| Gross margin | 65.6% | 46.7% | 49.3% | 43.7% |
| Selling, general and administrative | 3.4 | 0.8 | 0.1 | 0.1 |
| Sales and marketing | 0.6 | 0.2 | 0.0 | 0.0 |
| Research and development | 1.0 | 0.7 | 0.8 | 0.8 |
| EBIT | 3.7 | 0.6 | 0.4 | 0.5 |
| EBIT margin | 73.5% | 27.6% | 39.6% | 51.6% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | 3.7 | 0.8 | 0.6 | 0.5 |
| Net margin | 73.6% | 39.7% | 64.8% | 61.4% |
| |
| Diluted EPS | $0.49 | $0.24 | $0.26 | |
| Shares outstanding (diluted) | 7.5 | 3.5 | 2.5 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|